With Unilever set to leave the FTSE 100, is now the time to buy Reckitt Benckiser shares?

Here’s why Andy Ross believes shares in Reckitt Benckiser Group plc (LON:RB) will rise when Unilever plc (LON:ULVR) leaves the FTSE 100 (INDEXFTSE: UKX)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The consumer goods giant Unilever (LSE: ULVR) is looking to simplify its structure by moving to the Netherlands, meaning it will have to leave the FTSE 100.

Although many investors including Aviva and Lindell Train are openly opposed to the move, it is likely the company will end up getting its own way.

With that in mind, does that make now the ideal time to buy into the shares of another consumer goods giant, Reckitt Benckiser (LSE: RB), which is also a major FTSE 100 constituent?

Steady as she goes

Up to the announcement in March this year, Unilever had been an investor favourite, offering steady and dependable growth – resulting in those buying the shares being prepared to pay a premium. Defensive shares such as Unilever have been highly prized by those looking to grow their wealth against a backdrop of Brexit, a Trump presidency and other events that have created bouts of investor panic in recent years.

Reckitt Benckiser, although smaller than Unilever, has also benefitted from positive investor sentiment. The share price and dividend have been consistently edging up, which is great news for those holding the shares.

In its latest results, Reckitt’s first-half pre-tax profit rose 9.5% as it lifted its full-year revenue target on the back of strong infant formula sales.

Critically, the results showed its $17bn acquisition of infant formula group Mead Johnson was benefitting Reckitt and integration is on track and progressing well.

At the same time as these results, UBS posted an upbeat analysis stating that the quarter marked the “end of a long downgrade cycle for RB, in our view”.

Moving on from past errors

Reckitt is not immune, though, from making costly errors. Falling victim to a costly cyber-attack knocked the share price heavily in July 2017. Since then, though, the company has recovered and the impact on the share price and the company’s reputation has been minimal.

Another instance of succumbing to a data breach or cyber-attack would be much less forgivable. It seems though that all things considered, Reckitt has successfully moved on from past errors and could now be well positioned to benefit from Unilever shares dropping out of the FTSE 100.

A bright future

Reckitt to me looks like a great investment for anyone looking to grow their wealth through investing in stocks. Reckitt is a rare company that consistently provides its investors with both income and growth. The share price gains seen since the start of 2018 will continue and quite possibly accelerate if a major competitor drops out of the FTSE 100, I believe.

Even if investors can still buy shares in Unilever in 2019, I see no reason why Reckitt’s share price won’t still power ahead. Even without the backdrop of a major competitor leaving the UK, Reckitt is well positioned to keep growing and to keep elevating its share price.

Reckitt’s concentrated product portfolio, international markets, integration of a major acquisition and appeal to investors make it well worth researching further and are appealing to me at the current price. A price-to-earnings ratio of around 21 doesn’t put me off when the shares are so highly prized by investors.

Andy Ross does not own shares in any company mentioned. The Motley Fool UK owns shares of and has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »